Home › Companies › Biotechnology, Financial Services, Funding Platform, Oncology › Aglaia Oncology Funds
Aglaia Oncology Funds
Aglaia Oncology Funds is a financial service company that provides investment funds in the research of anti-cancer drugs.
Operating in biotechnology, financial services, funding platform, oncology based in European Union (EU), Europe, Middle East, and Africa (EMEA), Aglaia Oncology Funds was founded in 2004.
Within the biotechnology, financial services, funding platform, oncology space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in European Union (EU), Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Private company.
The company reports a headcount in the c_00001_00010 range.
| Sector | Biotechnology, Financial Services, Funding Platform, Oncology |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2004 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: aglaia-oncology.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account